Limiting factors in walking performance of subjects with COPD

Respiratory Care

Volumn 63, Issue 3, 2018, Pages 301-310

  Sanseverino, Marcela Alves ^a   Pecchiari, Matteo ^a,c   Bona, Renata Luisa ^d   Berton, Danilo Cortozi ^a,b,e   De Queiroz, Francisco Busolli ^b,e   Gruet, Mathieu ^f   Peyré Tartaruga, Leonardo A ^b  

^a Pathophysiology and Pulmonary Function Laboratory of Clinical Hospital of Porto Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^f UNIVERSITÉ DE TOULON   (France)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Fatigue; Gait; Oxygen consumption; Walking speed

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSPNEA; EXERCISE; FATIGUE; FEMALE; GAIT; HUMAN; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; SPIROMETRY; WALKING; WALKING SPEED; AGED; CASE CONTROL STUDY; COMPLICATION; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; LEG; MIDDLE AGED; MUSCLE FATIGUE; PATHOPHYSIOLOGY; PERCEPTION; PHYSIOLOGY; PSYCHOLOGY; VITAL CAPACITY; WALK TEST; WALKING DIFFICULTY;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEG; MALE; MIDDLE AGED; MOBILITY LIMITATION; MUSCLE FATIGUE; OXYGEN CONSUMPTION; PERCEPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY; WALK TEST; WALKING SPEED;

EID: 85048841678     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.05768     Document Type: Article

References (43)

1. Global Strategy for Diagnosis, Management and Prevention for Chronic Obstructive Pulmonary Diseases. www.goldcopd.org GOLD Report, Dec 2015.
2. Louvaris Z, Kortianou EA, Spetsioti S, Vasilopoulou M, Nasis I, Asimakos A, Zakynthinos S, Vogiatzis I. Intensity of daily physical activity is associated with central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol 2013;115(6):794-802.
3. Kawagoshi A, Kiyokawa N, Sugawara K, Takahashi H, Sakata S, Miur S, Sawamura S, Satake M, Shioya T. Quantitative assessment of walking time and postural change in patients with COPD using a new triaxial accelerometer system. Int J COPD 2013;8:397-404.
4. Karpman C, DePew ZS, LeBrausser NK, Novotny PJ, Benzo RP. Determinants of gait speed in COPD. Chest 2014;146(1):104-10.
5. O'Donnell DE, Webb KA. Point-counterpoint: the major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008;105(2):753-755.
6. Debigarè R, Maltais F. Point-counterpoint: the major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol 2008;105(2):751-753.
7. Aliverti A, Maklen PT. Point-counterpoint: the major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles. J Appl Physiol 2008;105(2):749-751.
8. Gomeñuka NA, Bona RL, Rosa RG, Peyré-Tartaruga LA. Adaptations to changing speed, load, and gradient in human walking: cost of transport, optimal speed, and pendulum. Scand J Med Sci Sports 2014;24:165-173.
9. Mian OS, Thom JM, Ardigo LP, Narici MV, Minetti AE. Metabolic cost, mechanical work, and efficiency during walking in young and older men. Acta Physiol 2006;186:127-139.
10. Figueiredo P, Ribeiro PAB, Bona RL, Peyré-Tartaruga LA, Ribeiro JP. Ventilatory determinants of self-selected walking speed in chronic heart failure. Med Sci Sports Exerc 2013;45(3):415-419.
11. Dubé BP, Agostoni P, Laveneziana P. Exertional dyspnoea in chronic heart failure: the role of the lung and respiratory mechanical factors. Eur Respir Rev 2016;25(141):317-332.
12. O'Donnell DE, Elbehairy AF, Faisal A, Webb KA, Neder JA, Mahler DA. Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev 2016;25(141):333-347.
13. Roig M, Eng JJ, Road JD, Reig WD. Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respir Med 2009;103:1257-1269.
14. Smith MD, Chang AT, Seale HE, Walsh JR, Hodges PW. Balance is impaired in people with chronic obstructive pulmonary disease. Gait Posture 2010;31:456-460.
15. Mortaza N, Abu Osman NA, Mehdikhani N. Are the spatio-temporal parameters of gait capable of distinguishing a faller from a non-faller elderly? Eur J Physical Rehab Med 2014;50(6):677-691.
16. Shimada H, Kim H, Yoshid H, Suzukawa M, Makizako H, Yoshida Y, et al. Relationship between age-associated changes of gait and falls and life-space in elderly people. J Phys Ther Sci 2010;22(4):419-424.
17. Guimaraes RM, Isaacs B. Characteristics of the gait in old people who fall. Int Rehabil Med 1980;2:177-180.
18. Annegarn J, Spruit MA, Savelberg HHCM, Willems PJB, van de Bool C, Schols AMJ, et al. Differences in walking pattern during 6-min walk test between patients with COPD and healthy subjects. PLoS One 2012;7(5):e37329.
19. Hausdorff JM. Gait variability: methods, modeling and meaning. J Neuroeng Rehabil 2005;2(19).
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
21. Pereira CAC, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33(4):397-406.
22. Barros RM, Brenzikofer R, Leite N, Figueroa PJ. Development and evaluation of a system for three-dimensional analysis of human movements. Br J Biomed Eng 1999;15:79-86.
23. Margaria R. Biomechanics and energetics of muscular exercise. Oxford: Clarendon Press; 1976:156.
24. Cavagna GA, Heglund NC, Taylor CR. Mechanical work in terrestrial locomotion: two basic mechanisms for minimizing energy expenditure. Am J Physiol 1977;233:R243-R261.
25. Levison H, Cherniak R. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 1968;25(1):21-27.
26. Milic-Emili G, Petit JM. Mechanical efficiency of breathing. J Appl Physiol 1960;15:359-362.
27. Palange P, Forte S, Onorati P, Manfredi F, Serra P, Carlone S. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 2000;88(5):1715-1720.
28. Filley FF. Pulmonary ventilation and the oxygen cost of exercise in emphysema. Trans Am Clin Climatol Assoc 1959;70:193-203.
29. Marin JM, Carrizo SJ, Gascon M, Sanches A, Galego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during 6-min walk test in the chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;148:1395-1399.
30. Callens E, Graba S, Gillet-Juvin K, Essali M, Bidaud-Chevalier B, Peiffer C, et al. Measurements of dynamic hyperinflation after 6-minute walk test in patients with COPD. Chest 2009;136(6):1466-1472.
31. Hausdorff JM, Rios D, Edelberg HK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil 2001;82(8):1050-1056.
32. Oliveira HB, da Rosa RG, Gomeñuka NA, Peyré-Tartaruga LA. Dynamic stability in stroke walking: the influence of speed. Rev Ed Física/UEM 2013;24(4):559-565.
33. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212:47-53.
34. Sheridan PL, Solomont J, Kowall N, Hausdorff JM. Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc 2003;51(11):1633-1637.
35. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(2):629-634.
36. Gabell A, Nayak US. The effect of age on variability in gait. J Gerontol 1984;39:662-666.
37. Verlinden VJ, van der Geest JN, Heeringa J, Hofman A, Ikram MA. Gait shows a sex-specific pattern of associations with daily functioning in a community-dwelling population of older people. Gait Posture 2015;41(1):119-124.
38. Yentes JN, Schimid KK, Blanke D, Romberger DJ, Rennard SI, Stergiu N. Gait mechanics in patients with chronic obstructive pulmonary disease. Respir Res 2015;16(1):31.
39. Lahousse L, Verlinden VJA, van der Geest JN, Joos GF, Hofman A, Stricker BHC, et al. Gait patterns in COPD: the Rotterdam Study. Eur Respir J 2015;46:88-95.
40. Malatesta D, Simar D, Dauvilliers Y, Candau R, Borrani F, Préfaut C, Caillaud C. Energy cost of walking and gait instability in healthy 65- and 80-yr-olds. J Appl Physiol 2003;95:2248-2256.
41. England SA, Granata KP. The influence of gait speed on local dynamic stability of walking. Gait Posture 2007;25(2):172-178.
42. Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD. Eur Respir Rev 2013;22:454-475.
43. Jordan K, Challis JH, Newell KM. Walking speed influences on gait cycle variability. Gait Posture 2007;26(1):128-134.